The LifeSign Status Respiratory Test Kit provides a reliable and rapid method for detecting SARS-CoV-2 nucleocapsid antigen, with results available in just 15 minutes. This kit is designed for point-of-care use and has received emergency use authorization (EUA) from the FDA. Each kit contains sufficient supplies for 25 tests, including test devices, extraction reagent capsules, and sterile swabs, along with positive and negative control swabs for quality assurance. The test can detect SARS-CoV-2 nucleocapsid antigen from nasal swab samples, typically within the first five days of symptom onset.